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Abstract
Background: Evidence indicates that supervised home exercises, combined or not with manual therapy, can be
beneficial for patients with non-specific chronic neck pain (NCNP). The objective of the study is to investigate the
efficacy of preventive spinal manipulative therapy (SMT) compared to a no treatment group in NCNP patients.
Another objective is to assess the efficacy of SMT with and without a home exercise program.
Methods: Ninety-eight patients underwent a short symptomatic phase of treatment before being randomly allocated
to either an attention-group (n = 29), a SMT group (n = 36) or a SMT + exercise group (n = 33). The preventive
phase of treatment, which lasted for 10 months, consisted of meeting with a chiropractor every two months to
evaluate and discuss symptoms (attention-control group), 1 monthly SMT session (SMT group) or 1 monthly SMT
session combined with a home exercise program (SMT + exercise group). The primary and secondary outcome
measures were represented by scores on a 10-cm visual analog scale (VAS), active cervical ranges of motion (cROM),
the neck disability index (NDI) and the Bournemouth questionnaire (BQ). Exploratory outcome measures were scored
on the Fear-avoidance Behaviour Questionnaire (FABQ) and the SF-12 Questionnaire.
Results: Our results show that, in the preventive phase of the trial, all 3 groups showed primary and secondary
outcomes scores similar to those obtain following the non-randomised, symptomatic phase. No group difference
was observed for the primary, secondary and exploratory variables. Significant improvements in FABQ scores were
noted in all groups during the preventive phase of the trial. However, no significant change in health related
quality of life (HRQL) was associated with the preventive phase.
Conclusions: This study hypothesised that participants in the combined intervention group would have less pain
and disability and better function than participants from the 2 other groups during the preventive phase of the
trial. This hypothesis was not supported by the study results. Lack of a treatment specific effect is discussed in
relation to the placebo and patient provider interactions in manual therapies. Further research is needed to
delineate the specific and non-specific effects of treatment modalities to prevent unnecessary disability and to
minimise morbidity related to NCNP. Additional investigation is also required to identify the best strategies for
secondary and tertiary prevention of NCNP.
Trial registration: ClinicalTrials.gov: NCT00566930
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Background
Non-specific neck pain is frequent, with an annual pre-
valence estimated to be 30% to 50% [1]. Often persistent
or recurrent, neck pain is still being reported by 50% to
85% of patients 1 to 5 years after initial onset [2]. Its
course is usually episodic, and improvement is of vari-
able degrees between episodes, but complete recovery is
unusual for most patients [3]. Manual therapy (mobilisa-
tion or manipulation), exercise intervention, low-level
laser therapy and, to a lesser extent, acupuncture, are
more effective than no treatment, sham, or alternative
interventions to stop episodes of neck pain. None of
these strategies is, however, superior to any other [4].
Evidence also indicates that supervised exercises with or
without manual therapy are better than usual or no care
[4] and that a multimodal care approach combining
exercise with manual therapy seems to be beneficial for
non-specific chronic neck pain (NCNP) [5]. Based on
care episodes of 6 to 8 weeks with various blends of
non-invasive interventions, [4] no particular course of
care improves the prognosis or appreciably affects the
natural history of neck disorder or its recurrence. Evi-
dence for the effectiveness of neck pain prevention stra-
tegies is therefore lacking.
Chiropractic intervention is usually directed toward
neuromusculoskeletal problems, [6] with around 25% of
patients presenting to a chiropractor and complaining of
neck pain [6,7]. Spinal manipulative therapy (SMT) is the
chiropractor’s main therapeutic tool. A holistic paradigm
is, however, at the foundation of this profession [8,9].
A recent review of chiropractic preventive care (CPC) [10]
indicates that more than 90% of surveyed chiropractors
believe that it is helpful to patients. In the realm of public
health, CPC is a strategy of tertiary prevention. In clinical
practice, it is scheduled at regular intervals, is usually elec-
tive and is not based on the occurrence of symptoms. It is
typically initiated after the resolution of a clinical problem,
and is designed to preserve optimum health while mini-
mizing recurrence. Only 1 randomised controlled trial
(RCT) investigating CPC efficacy in a non-specific low
back pain population has been published [11]. The results
indicated that the group receiving preventive SMT main-
tained improvement in disability level during the sympto-
matic period of care while the control group returned to
its pre-trial disability level. However, no differences
between the two groups were observed for pain. Other lit-
erature regarding CPC relates to surveys, focus groups,
reviews or editorials, [10,12-20], and many important
characteristics of CPC have not been studied, such as its
prevalence of use, its clinical indication, its effectiveness
and its acceptance by patients [10].
The objective of the study is to investigate the efficacy
of preventive SMT compared to a no treatment group
in NCNP patients. Another objective is to assess the
efficacy of SMT with and without a home exercise pro-
gram. It was hypothesised that during a 10-month per-
iod of preventive care, participants with NCNP receiving
SMT combined with a home exercise program would
have less pain and disability with improved function
compared to patients given only SMT or no treatment.
Methods
Participants
Study participants were recruited if they had NCNP,
defined as pain of mechanical origin located in the ana-
tomical region of the neck, with or without radiation to
the head, trunk or limbs, as described by Guzman et al
[3]. The inclusion criteria were: aged between 18 and
60 years, neck pain lasting 12 weeks or more, no physi-
cal therapy, not currently under chiropractic care or
rehabilitation for the neck area, willingness to adhere to
the treatment protocol, and signed informed consent.
Participants with concurrent headaches, non-radicular
pain in the upper extremities and lower back pain were
not excluded if neck pain was the main symptom. The
exclusion criteria included neck pain due to a motor
vehicle accident, neck surgery, severe osteoarthritis and
inflammatory arthritis, neurological, cardiovascular,
infectious metabolic and endocrine diseases, pregnancy
and any cardinal signs of potential vertebral artery
dissection.
Participants were recruited through radio and printed
advertisements aimed at the French-speaking commu-
nity of Trois-Rivières, Québec (population 126,000). The
study was carried out entirely at the chiropractic clinic
and human research laboratory of the Department of
Chiropractic at the Université du Québec à Trois-
Rivières. All participants gave their informed written
consent according to the research protocol approved by
the local ethics committee.
Three research assistants undertook standardised
phone screening regarding major inclusion and exclu-
sion criteria for study participation. Three other
research assistants, who were experienced chiropractors
and were blinded to future treatment allocation, per-
formed the preliminary standardised history-taking and
physical examination of eligible participants. Radio-
graphs of the cervical spine were ordered when indi-
cated [21]. All preliminary outcome measures were
collected at this point.
Randomisation and blinding
The trial was divided into 2 phases. The first was the
non-randomised, symptomatic phase during which all eli-
gible participants received a short course of SMT. After
completing the symptomatic phase, participants were
randomly assigned to one of three parallel groups. The
second phase, the preventive phase, lasted 10 months.
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Participants had an equal probability of assignment to
any 1 of the 3 groups. Each study participant was
assigned a number by the principal investigator (PI) who
put these numbers on individual cards in an opaque
envelope. An assistant, not involved in the research pro-
ject and blinded to the process, drew numbers from the
original, opaque envelope and arranged them in 3 differ-
ent opaque envelopes which were numbered 1 to 3.
Randomisation was concealed until the beginning of the
preventive treatment phase. No block or stratification
strategy was used in the randomisation process.
Randomisation was carried out after acceptance of the
appropriate number of participants into the study and
before beginning the non-randomised, symptomatic
phase. The PI opened the sealed, opaque envelopes after
the symptomatic phase was over, and baseline (second
set) outcome measures were collected. Each participant
was assigned to his/her appropriate group before begin-
ning the preventive phase of the trial. They remained on
the same allocation throughout the entire period if they
continued in the trial.
A credible placebo for SMT of patients previously
administered this type of therapy does not exist, espe-
cially if its specific and non-specific effects are consid-
ered [22-24]. Therefore, neither the participants, the
treating chiropractors nor the assessors were blinded to
treatment allocation for the future preventive phase of
the trial. Only the data analyst was blinded to treatment
allocation.
Interventions
During the symptomatic phase of the trial, all eligible
participants received a short course of SMT designed
to relieve symptoms. A team of 3 chiropractors using
high velocity low amplitude spinal manipulation [8]
and with at least 3 years of experience was responsi-
ble for treating the study participants. The interven-
tions were standardised beforehand and lasted 10 to
15 minutes. Between 10 and 15 treatments were pro-
vided over a 5- to 6-week period. Each treatment con-
sisted of a maximum of 4 spinal manipulations to the
cervical and upper thoracic areas (down to T4). Myo-
fascial soft tissue therapy (brief trigger point therapy)
was permitted but was to be kept to a minimum. No
advice or educative strategies were allowed. At this
stage, the chiropractors and study participants were
blinded to treatment allocation for the preventive
phase.
The preventive phase of the trial lasted 10 months
during which the participants attended the clinic regu-
larly. A chiropractor with at least 3 years of experience
was in charge of the interventions for each group. The
interventions were standardised beforehand. Medication
(s) and co-intervention such as other manual therapies,
physiotherapy, massage therapy as well as any other
common neck pain treatment were discouraged. Before
adopting any such pain control strategy, the participants
were instructed to first call their treating chiropractor to
discuss the problem. Patients in all 3 groups received
identical verbal and written instructions regarding
co-interventions and were asked to record any co-
interventions in a personal diary. Patients were given an
ice pack that could be used whenever pain intensity
reached a level of 5/10. Again all 3 groups received
identical instructions concerning ice application.
At each visit, the chiropractor asked the participants
for a standardised, short health history regarding symp-
toms during the last period and had them complete a
visual analog scale (VAS) for current symptoms. The
chiropractor also performed standardised passive palpa-
tion of the cervical and upper thoracic spine. No advice
or educative strategy was allowed during this phase, nor
was any type of soft tissue therapy. Diaries were distrib-
uted at these visits. Other interventions during each
visit were specific for each of the 3 groups:
Spinal manipulation group
This group received a maximum of 4 spinal manipulations
to the cervical and upper thoracic areas. They were given
1 treatment per month that lasted 10 to 15 minutes.
Spinal manipulation combined with a home exercise
program group
This group received a maximum of 4 spinal manipula-
tions to the cervical and upper thoracic areas (down to
T4). They were dispensed with 1 treatment per month,
and each of them lasted 10 to 15 minutes.
Participants were advised to perform a home exercise
program at least 3 times a week. The program was
designed by an experienced kinesiologist and required
low technology equipment (elastic tubing and foam phy-
sioballs). It included general range of motion (ROM)
exercises that served for warm-up and cool down pur-
poses, followed by 4 stretching/mobilization and 4
strengthening exercises (concentric and isometric con-
tractions) of the cervical and upper thoracic spine, prin-
cipally flexion/extension, lateral flexion and rotation of
the cervical spine. Three series of each exercise were
performed during a training session, with a 30- to
60-second rest period between each series. A complete
training session lasted between 20 to 30 minutes.
All participants were instructed to follow the same
exercise routine. However, exercise volume was tailored
to each participant’s strength and flexibility as well as
his/her ability to complete the routine with minimal
neck pain. Each patient received a written copy of the
program. At trial onset, a kinesiologist met each partici-
pant individually on 2 different occasions to instruct
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and correct them on execution of the exercises. Between
these 2 meetings, follow-up was conducted through
phone interviews to answer questions and confirm that
the exercises were not triggering cervical pain. The kine-
siologist met the participants individually every 2 months
(during the regular treatment visit) to ensure full under-
standing, appropriate execution and compliance. Minor
changes were made only when exercises produced
symptoms or when a patient was unable to perform a
specific exercise. During the 10 months of the preven-
tive phase, exercise type and volume could be modified
under the following conditions: exercise-related pain
described by the patient or major difficulty in carrying
out an exercise.
Attention-control group
This group received no treatment (no SMT or exercise
program) but each participant attended the clinic once
every 2 months. To give all trial participants the same
attention, each visit lasted twice as long as the other two
groups treatment time, specifically 20 to 30 minutes. The
same procedures as for the other 2 groups were performed
at these meetings (standardised short health history, VAS,
standardised passive palpation and the distribution of dia-
ries) but with much slower flow. As with the 2 other
groups, no advice or educative strategy was allowed.
Outcomes
Primary and secondary outcome measures
The primary outcome measure throughout the trial was
pain level. Pain was scored with a 10-cm VAS. The psy-
chometric properties of the VAS have been studied
extensively [25]. The number of patients that stayed
below a level of clinically acceptable pain (2 point differ-
ence from the symptomatic phase baseline VAS score)
during the preventive phase of the trial was also
assessed. For example, a patient that went from a score
of 5 to 3 on the VAS during the symptomatic phase and
maintained or improved this score throughout the pre-
ventive phase was considered to show a clinically mean-
ingful response. Function and disability were considered
the secondary outcomes in the study. Cervical spine
function was assessed with the cervical range of motion
instrument (cROM©). Many studies have demonstrated
acceptable validity and reliability of this instrument [26].
Active cervical bilateral rotation, bilateral lateral flexion,
and flexion and extension were measured with the
patient in the seated position. The patient performed
each active cROM three consecutive times in sequence-
specific order. The mean of the 3 consecutive readings
was used in this study. Disability was measured with the
Neck Pain Disability Index (NDI) and the Bournemouth
Questionnaire (BQ). The psychometric properties of
these 2 instruments, including their translation into the
French language [27,28] have been thoroughly assessed
and are adequate for such a trial [28-32].
Exploratory outcome measures
Exploratory outcome measures included health-related
quality of life (HRQOL), fear and avoidance phenomena,
exercise adherence and co-intervention. HRQOL and fear
avoidance phenomena were scored with the SF-12 Ques-
tionnaire [33] and the Fear-avoidance Behaviour Ques-
tionnaire (FABQ), [34] respectively, whose psychometric
properties are adequate for such a trial. The physical
health composite score and the mental health score from
the SF-12 were calculated.
Exercise adherence and co-intervention were mea-
sured through a diary that patients completed on a
weekly basis. Use of co-intervention, registered by the
patients, was calculated by adding up the number of co-
intervention episodes from one visit to another. Also
recorded were the frequency of ice application due to
pain intensity greater than 5/10 and the use of analge-
sics or consultation with other professionals for pain
management. Patients performing home exercises also
recorded the dates of their 3 weekly exercise sessions.
Outcome measures
Preliminary data were collected after participants signed
an informed consent form, before the beginning of the
non-randomised, symptomatic phase of the trial. Base-
line data were gathered once the symptomatic phase
was over, on specific appointment. During the 10 months
of the preventive phase, all outcomes were noted every 2
months. For the groups receiving treatments, these mea-
surements were recorded before the treatments.
For preliminary and baseline data, the assessors were
blinded to group allocation. The assessors were not
blinded to the data during the preventive phase but
were trained before the trial to ensure standardisation of
the outcome measures.
Statistical analysis
Sample size
Thirty-five participants per group were required to have a
90% chance of detecting a significant difference between
groups in the mean of VAS scores (i.e. a 2-point difference
on the VAS at the 2-sided 5% level) with an assumed stan-
dard deviation of 2.5 and a loss to follow-up of 20%. Since
no RCT on the efficacy of preventive spinal manipulation
for chronic cervical pain has been performed in the past,
the 20% loss to follow-up level was estimated from the
results of a similar RCT on the efficacy of preventive
spinal manipulation for chronic lumbar pain [11]. The
effect size was also estimated from this trial.
Statistical methods
All data were analysed according to a pre-established
experimental design using Version 6.1 of Statistica
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software. One-way ANOVA was performed for baseline
values of continuous variables. T-tests for dependent
samples were conducted on primary and secondary out-
comes to analyse data from the symptomatic phase of
the trial (pooled data).
The main analysis was undertaken on an intention-to-
treat basis. Missing values were imputed on the basis of
the last-observation-carried-forward technique and
included all randomly-assigned participants who stayed
in the study until the first visit of the preventive phase.
All clinical variables were analyzed using ANCOVA,
with treatment and time intervals representing the main
factors. Gender, age and pain improvement in the symp-
tomatic phase were used as covariates in the analyses.
Data were adjusted for gender and pain improvement in
the symptomatic phase because these 2 variables were
deemed to play an important role in possible further
improvement of the patient’s condition. One-way
ANOVA served to compare co-intervention data across
the 3 groups.
Whenever factorial analyses revealed significant
effects, post hoc analyses were performed with the least
significant difference test. For all analyses, statistical sig-
nificance was set at p < 0.05.
Results
Participant flow and follow-up
Patients were recruited during the months of August
and September 2007. One hundred and seventeen parti-
cipants were assessed for eligibility through an initial
evaluation in September 2007. Preliminary data were
collected at this time. All included participants (n =
108) received treatments during the symptomatic phase
of the trial, which began in September 2007. Ten
patients (randomized but no allocated) dropped out of
the study. This phase ended in December 2007, at
which point baseline data were collected. After complet-
ing symptomatic treatments, participants were assigned
to their groups. Drop outs from the symptomatic phase
led to unequal group sizes: SMT (n = 36), SMT + exer-
cise (n = 33) or attention-control (n = 29). The preven-
tive phase lasted from January 2008 to October 2008, at
which point all participant follow-up ended (Figure 1).
There was no deviation from the protocol or any serious
adverse events during the RCT.
Baseline demographics and clinical characteristics of each
group
The baseline demographics and clinical characteristics of
participants (measured before the symptomatic phase of
the trial), presented in Table 1, show that the percentage
of males was considerably lower in the attention-control
group than in the 2 experimental groups. Regarding the
duration of symptoms, fewer participants from the
attention-control group had pain for less than 1 year
compared to the 2 experimental groups (3.7% versus
9.3% and 9.1%). The other baseline characteristics were
similar between the 3 groups, indicating that randomisa-
tion was successful for these variables. The mean pain
score of 3.6 cm on the VAS and the mean disability
score of 23.1 on the NDI indicated the severity of com-
plaints and the underlying disability. Active ROMs were
reported for each plane and were not divided into right/
left or flexion/extension.
Non-randomised symptomatic phase
During the non-randomised, symptomatic phase of this
trial, the average pain level of participants decreased by
1.2 cm on the VAS, the disability level declined by 4.9
points on the NDI and by 6.5 points on the BQ. Func-
tion, measured as active cROMs, improved by 6.5° in
the axial plane (rotation), 2.4° in the coronal plane (lat-
eral flexion) but decreased by 14.1° in the sagittal plane
(flexion-extension). These differences were all statisti-
cally significant, except for lateral flexion (Table 2).
Clinical significance thresholds have been proposed for
many neck pain clinical outcomes (1/10 for VAS, 8/100
for NDI and 4.4/70 for BQ) [27,35,36]. Thus, VAS and
BQ reached clinically significant changes. Clinical signif-
icance values for ROM have not been established in
NCNP patients.
Preventive phase - Primary and secondary outcomes
Although improvement was significant on the NDI, BQ
and lateral flexion ROM in all groups, ANCOVA
(adjusted for gender and pain improvement in the
symptomatic phase) did not yield significant between
group differences for the primary and secondary out-
come measures. Table 3 reports mean (SD) values and
95% confidence intervals for the primary and secondary
outcomes, namely, VAS, NDI, BQ and active cROMs, in
the baseline, initiation of RCT, mid-trial and end of
trial. Improvement in pain and disability status (NDI
and BQ scores) over time is illustrated in Figure 2. Even
though no significant group differences could be found,
a trend was observed toward a progressive decrease in
disability level for both variables. Overall a majority of
the participants in the attention-control group (16
patients; 55%), the SMT group (20 patients; 56%) and
the SMT + exercise group (24 patients; 73%) stayed
below a level of clinically acceptable pain (2 point differ-
ence from the symptomatic phase baseline VAS score)
during the preventive phase of the trial during the pre-
ventive phase of the trial.
Preventive phase - exploratory outcomes
Significant improvements in FABQ scores (work and
physical activity-related scores) over time were noted in
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all groups. Statistical analysis of HRQOL (physical
health composite score and mental health score from
the SF-12) did not yield any significant effect. Table 4
presents the mean (SD) values and 95% confidence
intervals for the secondary outcomes.
Compliance, exercise adherence and co-intervention
The overall compliance of each participant for all groups
(excluding the patients who dropped-out during the ran-
domized phase of the trial) was 96% (8.2) for the atten-
tion-control group and 96% (6.3) and 93% (9.8) for SMT
 
 
       
 
 
 
 
 
 
 
 
Assessed for eligibility 
(n=117) 
Excluded (n= 9) 
 
  Not meeting inclusion criteria  
(n=4) 
  Refused to participate (n=2) 
  Other reasons (n=3) 
Analyzed (n=32) 
    
Lost to follow-up (n= 0) 
 
SMT group 
(n=36) 
Received intervention (n=32) 
 
Did not receive intervention (n=4) 
No specific reason given 
Allocation 
Analysis 
Enrollment 
Randomised (n=108) 
Assessed by phone for 
eligibility (n= 175) 
Excluded  (n=58) 
Symptomatic phase of treatments – all participants (n=108) 
SMT + Exercise group 
(n=33) 
Received intervention (n=33) 
 
Did not receive intervention (n=0) 
Control group 
(n=29) 
Received intervention (n=27) 
 
Did not receive intervention (n=2) 
Dropped out because of treatment 
allocation 
Lost to follow-up (n= 1) 
  
Discontinued care without 
specific reason 
Lost to follow-up (n= 1) 
 
Discontinued care without 
specific reason 
 
Analyzed (n=32) 
    
Analyzed (n=27) 
    
Follow-Up 
Dropped out during 
intensive phase (n= 10) 
Analysis Analysis 
Figure 1 Progression of participants through the trial including withdrawal and exclusion.
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and SMT+ exercise groups respectively. Patients’ diaries
were consulted to verify exercise adherence in the com-
bined intervention group and co-intervention along with
ice application in all patients. Mean adherence to the
home exercise program (exercise sessions completed/
total number of possible sessions) was 48.8%. Out of 26
patients in the combined intervention group, 16 (61.5%)
completed more than 50% of the exercise sessions, 6
(23.1%) finished less than 50%, and 4 (15.4%) did not
adhere at all to the program.
Significant between group differences were noted for
both the number of co-intervention episodes (p = 0.006)
and ice application (p = 0.032). The attention-control
group required significantly more co-intervention (7.6 ±
1.1) compared to the other 2 groups (4.1 ± 0.9 and
2.9 ± 0.9). Moreover, the attention-control group chose
to apply ice as a pain-relieving modality significantly
more often (20.8 ± 4.7) that the other 2 groups (7.8 ±
4.0 and 4.5 ± 4.2). Figure 3 reports the co-intervention
and ice-use data for all groups.
Table 1 Baseline characteristics of patients enrolled in the trial
Characteristics Spinal manipulation Spinal manipulation + Home exercise program Attention-control
Mean age (SD), years 36.8 (10.5) 43.3 (10.5) 43.3 (10.9)
Sex = male (%) 39.4% 42.4% 20.7%
Height (SD), m 153.8 (29.9) 155.7 (34.8) 144.9 (33.2)
Weight (SD), kg 65.8 (3.0) 66.1 (3.7) 64.8 (4.1)
Category of pain duration, n (%)
1 - Less than 6 months 1 (3.1%) 0 0
2 - Between 6 months & 1 year 2 (6.2%) 3 (9.1%) 1 (3.7%)
3 - Between 1 & 2 years 6 (18.8%) 0 7 (25.9%)
4 - Between 2 & 3 years 7 (21.9%) 7 (21.2%) 4 (14.8%)
5 - Between 3 & 5 years 4 (12.5%) 6 (18.2%) 5 (18.5%)
6 - Between 5 & 10 years 5 (15.6%) 4 (12.1%) 8 (29.6%)
7 - More than 10 years 7 (21.9%) 13 (39.4%) 2 (7.4%)
Mean pain = VAS (SD), cm 3.1 (2.1) 3.8 (2.6) 3.8 (2.5)
Mean disability = NDI (SD) 21.4 (8.8) 22.2 (9.0) 25.6 (10.0)
Mean disability = BQ (SD) 26.4 (10.4) 22.4 (11.7) 27.7 (12.2)
Rotation (SD), ° 117.6 (15.3) 113.0 (21.3) 114.4 (16.2)
Lateral flexion (SD), ° 64.8 (17.9) 59.3 (14.8) 63.4 (13.4)
Flexion-extension (SD), ° 109.7 (19.9) 104.0 (21.4) 100.8 (19.8)
SF-12, physical scale 48.7 (5.6) 50.0 (7.2) 47.3 (7.6)
SF-12, mental scale 45.3 (9.9) 44.8 (9.0) 46.7 (10.4)
FABQ-1, work-related 10.5 (8.7) 10.7 (8.0) 14.1 (7.7)
FABQ-2, physical-activity related 6.6 (5.7) 7.5 (6.2) 7.6 (6.4)
SD = standard deviation, VAS = Visual analog scale, NDI = Neck disability index, BQ = Bournemouth questionnaire, FABQ-1 = Fear-avoidance questionnaire-1
work-related, FABQ-2 = Fear-avoidance questionnaire-2 physical activity-related.
Table 2 Primary and secondary outcomes results of the symptomatic phase of treatments (non-randomised
intervention)
Outcome measures Before treatments After treatments Difference p value
Mean pain: VAS (SD), cm 3.4 ± 2.3 [0-8.1] 2.3 ± 1.9 [0-8.5] 1.1 p = 0.0003
NDI (SD) 22.9 ± 9.3 [0-52] 18.0 ± 9.6 [0-44] 4.9 p = 0.0005
BQ (SD) 25.3 ± 11.6 [2-57] 18.9 ± 10.9 [2-56] 6.5 p = 0.0001
Range of motion (°)
Rotation (SD) 115.2 ± 17.6 [65-151] 121.7 ± 17.4 [73-160] 6.5 p = 0.0161
Lateral flexion (SD) 63.9 ± 17.0 [28-104] 66.3 ± 15.3 [23-110] 2.4 p = 0.3423
Flexion-extension (SD) 119.4 ± 19.0 [52-166] 105.3 ± 20.5 [52-151] 14.1 p < 0.0001
Mean values, standard deviation as well as minimal and maximal values are indicated.
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Discussion
Principal findings, possible mechanisms and explanation
of results
This study hypothesised that participants in the com-
bined intervention group would have less pain and dis-
ability and better function than participants from the 2
other groups during the preventive phase of the trial. In
fact, all 3 groups showed primary and secondary out-
comes scores similar to those obtained following the
non-randomised, symptomatic phase. No significant
change in HRQOL was associated with the preventive
phase, but the 3 groups demonstrated statistically signif-
icant improvement in their fear avoidance behaviour
scores over time. Overall spinal manipulation or spinal
manipulation combined with exercises did not yield sig-
nificant advantages when compared to the no treatment
strategy.
The course of neck pain is usually described as epi-
sodes occurring over a lifetime with variable degrees of
recovery between episodes [2,3,37]. Furthermore, prior
pain episodes are associated with poorer prognosis. In
our study, more than 75% of experienced NCNP,
defined as recurring episodes or continuous pain, for
more than 2 years at study onset. Given the course
and natural history of neck pain, we expected that
pain, function and disability of participants in the
attention-control group would regress to pre-treatment
levels during the 10 months of the preventive phase.
Stabilisation of improvement in the attention-control
group after the symptomatic phase raises questions
regarding the causality of this change in the course of
the disorder. One hypothesis relates to the attention-
control group requiring more co-intervention of any
type and choosing ice as a pain-relieving modality sig-
nificantly more often than the 2 other groups. These
additional strategies of self-management in terms of
symptom attention-control and coping might explain,
at least partially, the equivalence of the 3 groups in
terms of pain, function and disability during the pre-
ventive phase of the trial.
Another plausible explanation for these results is the
placebo effect, which refers to the outcome attributable to
Table 3 Mean (SD) values and 95% confidence interval for the primary and secondary outcomes
Outcome
measure
Group Baseline Initiation of RCT Mid-trial End of trial
Mean pain:
VAS (SD), cm
Attention-
control
3.8 ± 1.9 (3.0 to 4.5) 2.5 ± 2.1 (1.8 to 3.3) 3.3 ± 2.6 (2.2 to 4.3) 2.9 ± 2.9 (1.9 to 4.0)
SMT 3.3 ± 1.7 (2.7 to 3.9) 2.1 ± 1.7 (1.5 to 2.7) 2.3 ± 2.3 (1.5 to 3.1) 2.1 ± 2.3 (1.2 to 2.9)
SMT +
exercises
3.4 ± 1.7 (2.9 to 4.0) 2.2 ± 1.7 (1.6 to 2.8) 2.1 ± 2.3 (1.3 to 2.9) 1.6 ± 2.3 (0.8 to 2.4)
NDI Attention-
control
26.1 ± 12.7 (21.4 to 30.9) 25.5 ± 4.5 (17.8 to 27.2) 20.2 ± 13.8 (15.0 to 25.4) 21.5 ± 14.0 (16.1 to 26.8)
SMT 21.5 ± 10.7 (17.8 to 25.2) 15.7 ± 10.7 (12.0 to 19.4) 14.9 ± 11.8 (10.8 to 19.0) 13.7 ± 12.1 (9.5 to 17.9)
SMT +
exercises
21.4 ± 10.4 (17.8 to 25.0) 15.5 ± 10.4 (11.9 to 19.1) 13.5 ± 11.6 (9.5 to 17.5) 11.3 ± 11.8 (7.3 to 15.4)
Bournemouth Attention-
control
29.8 ± 15.4 (23.9 to 35.6) 22.1 ± 14.8 (16.6 to 27.7) 16.7 ± 11.7 (12.3 to 21.1) 18.6 ± 12.7 (13.7 to 23.4)
SMT 27.0 ± 12.7 (22.7 to 31.4) 18.6 ± 12.1 (14.4 to 22.8) 10.9 ± 9.5 (7.6 to 14.2) 12.8 ± 10.4 (9.2 to 16.4)
SMT +
exercises
21.5 ± 13.0 (16.9 to 26.0) 15.3 ± 12.7 (10.9 to19.7) 10.8 ± 10.1 (7.4 to 14.3) 8.5 ± 11.0 (4.6 to 12.3)
Flexion-
extension
Attention-
control
110.0 ± 22.8 (101.5 to 118.6) 100.8 ± 21.2 (92.8 to 108.8) 106.3 ± 19.1 (99.0 to 113.5) 106.1 ± 23.3 (97.4 to 114.9)
SMT 124.5 ± 16.5 (118.8 to 130.2) 108.5 ± 20.5 (101.5 to 115.6) 114.4 ± 22.5 (106.5 to 122.2) 114.1 ± 21.0 (107.0 to 121.3)
SMT +
exercises
124.5 ± 16.5 (118.8 to 130.2) 105.8 ± 25.1 (97.1 to 114.5) 115.5 ± 16.2 (109.9 to 121.1) 115.6 ± 22.5 (107.8 to 123.4)
Rotation Attention-
control
114.0 ± 19.1 (106.8 to 121.2) 118.1 ± 17.5 (112.1 to 124.7) 118.4 ± 15.9 (112.4 to 124.4) 119.5 ± 15.4 (113.6 to 125.3)
SMT 117.1 ± 17.0 (111.2 - 123.0) 124.9 ± 17.6 (118.7 - 131.0) 123.4 ± 28.0 (113.7 - 133.1) 126.9 ± 29.5 (116.7 - 137.1)
SMT +
exercises
114.7 ± 24.8 (106.1 - 123.3) 120.9 ± 20.5 (113.9 - 128.0) 122.8 ± 30.3 (112.3 - 133.3) 126.7 ± 25.7 (117.8 - 135.6)
Lateral Flexion Attention-
control
63.7 ± 15.4 (58.0 - 69.5) 68.8 ± 13.2 (63.7 - 73.8) 74.7 ± 15.9 (68.8 - 80.7) 70.5 ± 11.1 (66.2 - 74.7)
SMT 66.3 ± 20.8 (59.1 - 73.5) 68.9 ± 15.3 (63.6 - 74.2) 75.8 ± 24.5 (67.2 - 84.3) 67.1 ± 13.6 (62.5 - 71.8)
SMT +
exercises
59.4 ± 17.9 (53.2 - 65.6) 59.6 ± 17.3 (53.6 - 65.6) 68.1 ± 18.5 (61.7 - 74.5) 70.8 ± 23.7 (62.6 - 79.0)
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a procedure but not to its specific properties. Any per-
ceived therapeutic action includes its specific and non-
specific effects. The non-specific effects, also termed the
“context of treatment”, represent the psychosocial aspect
of every treatment. In our study, different clinicians were
responsible for each of the 3 groups, and therefore the
treating clinician (not only the treatment used) may have
influenced the clinical outcomes. Many factors contribute
to these outcomes, the 3 most often described being the
patient, the provider and patient-provider interaction
Figure 2 Mean (SD) VAS, NDI and Bournemouth scores during the preventive phase of the trial.
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[38-41]. From the patient’s perspective, the magnitude of
the placebo response is highly variable between indivi-
duals, [38,40] and patients’ expectations influence treat-
ment outcomes, including the specific and non-specific
effects [41]. Chronic conditions with fluctuating courses,
such as chronic neck pain, are usually more placebo-prone
[39,41]. Finally, many studies indicate that patient-provider
interaction is a potent factor in health outcomes
[38,39,41]. Many factors, such as a clear diagnosis, an
opportunity for dialogue or the overall “context of treat-
ment”, play a definite part in the placebo effect. It is there-
fore possible that being enrolled in a formal research
project in a university setting heightens participants’
expectations of improvement, leading to an enhanced pla-
cebo effect and explaining, at least partially, the uniform
response in the 3 groups. These non-specific effects would
be principally attributable to the participants themselves
and participant-provider interaction. The statistically sig-
nificant recovery in the 3 groups in fear avoidance beha-
viour scores over time might be an indication of such
positive participant-provider interaction.
Exercise adherence in the combined intervention
group was 48.8%. This compares with previous estimates
of adherence in home exercise programs for neck and
low back pain, converging around 50% [42,43]. This
may in fact reflect the highest level of adherence for
these clinical populations. Considering the overall bene-
fits and relatively low risk associated with exercise, clini-
cians may consider this therapy has an adjunct to SMT.
However, several factors, such as frequent supervision
Table 4 Mean (SD) values and 95% confidence interval for the exploratory outcomes
Outcome measure Group Baseline Initiation of RCT Mid-trial End of trial
FABQ 1/42* Attention-control 14.7 ± 8.5 (11.5 to 17.9) 14.0 ± 9.0 (10.5 to 17.4) 7.8 ± 8.5 (4.4 to 11.1) 8.8 ± 9.5(5.2 to 12.4)
SMT 10.4 ± 9.2 (7.2 to 13.6) 10.5 ± 8.1 (7.7 to 13.3) 6.9 ± 7.8 (4.2 to 9.6) 6.2 ± 8.1 (3.5 to 9.0)
SMT + Exercises 11 ± 11.0 (7.2 to 14.8) 7.6 ± 8.7 (4.5 to 10.6) 6.1 ± 9.0 (3.2 to 9.2) 4.7 ± 9.5 (1.5 to 8.0)
FABQ 2/24** Attention-control 8.2 ± 7.4 (5.5 to 11.0) 7.7 ± 7.4 (4.9 to 10.5) 7.2 ± 6.9 (4.6 to 9.8) 5.4 ± 5.8 (3.2 to 7.6)
SMT 7.2 ± 6.1 (5.1 to 9.3) 6.2 ± 6.6 (3.9 to 8.5) 4.8 ± 6.1 (2.7 to 6.9) 5.7 ± 5.2 (3.9 to 7.5)
SMT + Exercises 7.7 ± 7.8 (5.0 to 10.4) 5.8 ± 7.2 (3.2 to 8.3) 3.3 ± 6.6 (1.0 to 5.6) 2.0 ± 5.8 (0.1 to 4.0)
SF-12 (physical) Attention-control 47.3 ± 8.5 (44.2 to 50.5) 47.5 ± 9.0 (44.1 to 50.9) 50.5 ± 9.3 (47.1 to 54.0) 52.1 ± 8.2 (49.0 to 55.2)
SMT 48.9 ± 6.4 (46.7 to 51.1) 52.1 ± 8.4 (49.8 to 55.0) 51.1 ± 7.8 (48.5 to 53.8) 53.1 ± 6.9 (50.7 to 55.5)
SMT + Exercises 49.9 ± 8.7 (47.0 to 52.9) 51.7 ± 7.8 (49.1 to 54.4) 52.1 ± 7.8 (49.5 to 54.8) 54.1 ± 7.2 (51.7 to 56.6)
SF-12 (mental) Attention-control 51.3 ± 9.3 (47.7 to 54.8) 51.0 ± 11.9 (46.4 to 55.5) 52.6 ± 11.4 (48.2 to 56.9) 49.9 ± 10.1 (46.1 to 53.7)
SMT 47.9 ± 9.8 (44.5 to 51.3) 48.3 ± 10.1 (44.8 to 51.8) 49.6 ± 9.8(46.3 to 53.0) 52.3 ± 8.4 (49.3 to 55.2)
SMT + Exercises 47.5 ± 10.1 (43.9 to 51.0) 47.2 ± 10.1 (43.6 to 50.7) 48.5 ± 9.8(45.1 to 51.9) 49.8 ± 8.7 (46.9 to 52.8)
* FABQ 1 = Fear avoidance behaviour questionnaire - Work related score, maximum score of 42.
** FABQ 2 = Fear avoidance behaviour questionnaire - Physical activity related score, maximum score of 24.
Figure 3 Co-intervention and use of ice during the preventive phase of the trial. * Indicates a significant group difference in use of ice
and ** a significant group difference in co-intervention.
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and clarifications about exercises, are known to improve
compliance and should consequently be considered in
clinical trials involving exercise therapy [42].
Comparison with other studies
Before the preventive phase of this study, all participants
received a short course of treatment to relieve symptoms:
SMT to the cervical and upper thoracic areas and myofas-
cial soft tissue therapy when appropriate. All primary and
secondary outcomes (pain, function and disability) demon-
strated statistically significant improvement, except lateral
flexion. The results of this non-randomised, symptomatic
phase compare favourably to the existing literature on
SMT for NCNP [44-48]. The symptomatic phase of our
trial was unblinded and uncontrolled. It was, therefore,
not possible to draw a specific conclusion regarding the
causality of improvement, which might be attributed to
one or a combination of treatment efficacies, the placebo
effect, the natural history of the condition or the phenom-
enon of regression to the mean (spontaneous fluctuations
in pain levels which tend, on average, to revert towards
the mean). Furthermore, a more recent study [4] states
that the evidence is often conflicting regarding the benefits
of isolated manual therapy for NCNP.
Some trials have assessed the long-term efficacy and
effectiveness of SMT for non-specific neck pain
[44,49-51]. To our knowledge, this trial is the first to
investigate the preventive influence of SMT with or
without a home exercise program on NCNP. Given the
present results and the innovative nature of the study, it
is at this stage difficult to determine if the appropriate
dosage of SMT was applied.
Study strengths and limitations
The limitations of the present study include the absence
of blinding of participants or treating chiropractors.
This was inevitable due to the trial design (SMT for all
participants in the symptomatic phase) and the impossi-
bility of designing an adequate placebo for SMT [23,24].
Independent assessors, blinded to treatment allocation
and clinical evolution, could have been involved in the
trial. Physician global response assessed by a blinded
evaluator should be considered in future studies.
A crucial aspect of any clinical trial is the equivalency of
group sample size. In our RCT, randomisation was per-
formed before the beginning of the trial’s symptomatic
phase, and an unequal number of drop-outs generated a
smaller attention-control group than the experimental
groups. It should also be noted that since the sample size
of 35 subjects per group was not achieved, the pre-
established statistical power was not reached. Because of
the fluctuating nature of NCNP the patients included in
this trial presented with low pain scores, at the time of
enrolment. Such low levels of pain and related disabilities,
may have limited the ability to detect statistically and clini-
cally significant difference between the groups.
Another limitation is that during the preventive phase,
participants in the attention-control group consulted only
once every 2 months for a period of 20 to 30 minutes.
This contrasts with the 2 experimental groups who
consulted on a monthly basis for 10 to 15 minutes. The
difference in protocol was deemed necessary to minimize
drop-outs in the attention-control group. The actual drop-
out rate of the 3 groups was 11% for the SMT only group,
3% for the SMT combined with exercise group, and 10%
for the attention-control group. Since the attention-con-
trol group did not incur a higher drop-out rate compared
to the experimental groups, it can be concluded that this
was an adequate strategy. However, the impact of such a
strategy on clinical outcomes cannot be assessed indepen-
dently of the present study.
Despite these limitations, this small-scale RCT demon-
strates the feasibility of implementing controlled trials to
investigate preventive strategies to improve prognosis or
affect the natural history or recurrence of NCNP.
Conclusions
The results of our study are important because there has
been minimal previous research regarding the preven-
tion of NCNP. Our results suggest that the mere fact of
taking charge of and managing a patient for this condi-
tion might decrease the recurrence of pain episodes and,
therefore, change the course of the disease. Considering
the societal burden of NCNP, [1] the issue is worth
investigating, both in terms of treatment efficacy and
cost-effectiveness. Further research related to our
hypothesis might be conducted in the form of a RCT.
Our results also indicate that there is no additional ben-
efit for patients with NCNP to receive monthly preventive
SMT or monthly preventive SMT with a home exercise
program compared to meeting a chiropractor once every
2 months to discuss neck problems. In view of the rare
but possible adverse reactions to cervical SMT, this tends
to reject CPC when SMT is the main intervention. How-
ever, the premise of CPC stating that regular treatments,
designed to preserve optimum health, will also minimize
the recurrence of clinical problems, might hold true when
intervention is geared towards reassurance, patient educa-
tion, help with self-management and active care strategies.
Further research in this domain has to be conducted.
A final implication of these results is the equivalence
between the SMT and combined intervention groups.
The actual, best evidence regarding treatment for NCNP
is a combined approach involving manual therapy and
exercise [4]. It is possible that the best strategy for pre-
vention of NCNP might not be similar to the best strat-
egy for treatment of this condition. Further research is
warranted in this regard.
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